Patel Shaneel R, Roy Iain N, McWilliams Richard G, Brennan John A, Vallabhaneni Srinivasa R, Neequaye Simon K, Smout Jonathan D, Fisher Robert K
Department of Vascular Surgery, Royal Liverpool University Hospital, Liverpool, UK.
Department of Interventional Radiology, Royal Liverpool University Hospital, Liverpool, UK.
JRSM Cardiovasc Dis. 2021 Apr 28;10:20480040211012503. doi: 10.1177/20480040211012503. eCollection 2021 Jan-Dec.
In FEVAR, visceral stents provide continuity and maintain perfusion between the main body of the stent and the respective visceral artery. The aim of this study was to characterise the incidence and mode of visceral stent failure (type Ic endoleak, type IIIa endoleak, stenosis/kink, fracture, crush and occlusion) after FEVAR in a large cohort of patients at a high-volume centre.
A retrospective review of visceral stents placed during FEVAR over 15 years (February 2003-December 2018) was performed. Kaplan-Meier analyses of freedom from visceral stent-related complications were performed. The outcomes between graft configurations of varying complexity were compared, as were the outcomes of different stent types and different visceral vessels.
Visceral stent complications occurred in 47/236 patients (19.9%) and 54/653 stents (8.3%). Median follow up was 3.7 years (IQR 1.7-5.3 years). There was no difference in visceral stent complication rate between renal, SMA and coeliac arteries. Visceral stent complications were more frequent in more complex grafts compared to less complex grafts. Visceral stent complications were more frequent in uncovered stents compared to covered stents. Visceral stent-related endoleaks (type Ic and type IIIa) occurred exclusively around renal artery stents. The most common modes of failure with SMA stents were kinking and fracture, whereas with coeliac artery stents it was external crush.
Visceral stent complications after FEVAR are common and merit continued and close long-term surveillance. The mode of visceral stent failure varies across the vessels in which the stents are located.
在腔内修复腹主动脉瘤(FEVAR)中,内脏支架可提供连续性,并维持支架主体与相应内脏动脉之间的灌注。本研究的目的是在一个高容量中心的大量患者队列中,描述FEVAR后内脏支架失败(Ic型内漏、IIIa型内漏、狭窄/扭结、骨折、挤压和闭塞)的发生率及模式。
对15年期间(2003年2月至2018年12月)FEVAR过程中置入的内脏支架进行回顾性分析。对无内脏支架相关并发症的情况进行Kaplan-Meier分析。比较了不同复杂程度移植物构型之间的结果,以及不同支架类型和不同内脏血管的结果。
47/236例患者(19.9%)和54/653个支架(8.3%)发生了内脏支架并发症。中位随访时间为3.7年(四分位间距1.7 - 5.3年)。肾动脉、肠系膜上动脉(SMA)和腹腔干动脉之间的内脏支架并发症发生率无差异。与不太复杂的移植物相比,内脏支架并发症在更复杂的移植物中更常见。与覆膜支架相比,裸支架的内脏支架并发症更常见。内脏支架相关内漏(Ic型和IIIa型)仅发生在肾动脉支架周围。SMA支架最常见的失败模式是扭结和骨折,而腹腔干动脉支架则是外部挤压。
FEVAR后内脏支架并发症很常见,值得持续密切长期监测。内脏支架失败的模式因支架所在血管不同而有所差异。